Medically supervised GLP-1 programs with DEXA tracking and lab monitoring
Available from: Yong W, Shibo W, Jingang L
Emerging evidence further supports the potential role of GLP-1 RAs in improving dermatologic outcomes independently of metabolic improvements, suggesting a dual therapeutic mechanism
Kroon, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Instead, they were derived from large observational cohorts, retrospective comparative analyses, and pooled real-world datasets
The findings came after the UK Medicines and Healthcare products Regulatory Agency issued a drug safety update in February, warning about the risk of Naion